High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
Kristina IsandRichard FeeldersThierry BrueMiklos TothTimo DeutschbeinMartin ReinckeMichal KršekAlicia SantosFrank DemtröderOlivier ChabreChristian J StrasburgerAnna Aulinas MasoVallo VolkeAlberto M PereiraRüdiger LohmannIgnasi Gich Saladichnull nullSusan M WebbJohn WassElena ValassiPublished in: European journal of endocrinology (2024)
Patients with CS have an elevated risk of developing VTE for an extended period of time. From ERCUSYN cohort patients have higher risk for VTE if they need multiple surgeries to treat CS, are males and have high UFC values at the diagnosis of CS. Since there is no agreement on thromboprohpylaxis, a protocol for VTE prevention that is widely adopted appears to be necessary for patients with CS.
Keyphrases
- venous thromboembolism
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- randomized controlled trial
- prognostic factors
- peritoneal dialysis
- electronic health record
- coronary artery bypass
- acute coronary syndrome
- deep learning
- percutaneous coronary intervention
- surgical site infection
- data analysis